althiomycin
A peptide antibiotic isolated from soil and enteric bacteria. It is a protein synthesis inhibitor which exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria.
Classification
-
CHEBI:140325 -
CHEBI:140326 -
CHEBI:15734 -
CHEBI:22307 -
CHEBI:23763 -
CHEBI:25698 - peptide antibiotic
CHEBI:25903 -
CHEBI:38418 -
CHEBI:74222
Chemical structure
| Molecular formula | C16H17N5O6S2 |
|---|---|
| Charge | 0 |
| Average mass | 439.475 Da |
| Monoisotopic mass | 439.06203 Da |
| Source | ChEBI |
| InChIKey | VQQNQKXWJMRPHT-GMLCBOFYSA-N |
COC1=CC(=O)N(C(=O)[C@H]2CSC(C(CO)NC(=O)c3csc(/C=N/O)n3)=N2)C1
InChI=1S/C16H17N5O6S2/c1-27-8-2-13(23)21(4-8)16(25)11-7-29-15(20-11)9(5-22)19-14(24)10-6-28-12(18-10)3-17-26/h2-3,6,9,11,22,26H,4-5,7H2,1H3,(H,19,24)/b17-3+/t9?,11-/m1/s1
Also called
- 2-[(E)-(hydroxyimino)methyl]-N-(2-hydroxy-1-{(4S)-4-[(4-methoxy-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]-4,5-dihydro-1,3-thiazol-2-yl}ethyl)-1,3-thiazole-4-carboxamide
- 116-A
- N-{2-hydroxy-1-[(4S)-4-(4-methoxy-2-oxo-2,5-dihydro-1H-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-[(E)-(hydroxyimino)methyl]-1,3-thiazole-4-carboxamide
- altiomycin
- matamycin
Cross-references
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial agent
CHEBI:33282
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:157683 |
althiomycin | antibioticmech:chebi-8564797afb |
2026-08-30 |
Molecular targets
bacterial ribosomal peptidyl-transferase reaction BIOLOGICAL_PROCESS MEASURED_TARGET_ASSOCIATION
Escherichia coli NCBITaxon:562; strain B
- — "In the cell-free system althiomycin was confirmed to inhibit protein synthesis."
Mechanism summary
- Mode of action
- PROTEIN_SYNTHESIS_INHIBITION microbial target
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Bacillus subtilis NCBITaxon:1423 | ACTIVE | — | — | Growth inhibition by the diffusible product of Serratia marcescens Db10; althiomycin identity confirmed by chromatographic and spectroscopic analysis. | — | — | EvidencePage data (JSON.gz) |
| Staphylococcus aureus NCBITaxon:1280 | ACTIVE | — | — | Growth inhibition by the diffusible product of Serratia marcescens Db10; althiomycin identity confirmed by chromatographic and spectroscopic analysis. | — | — | EvidencePage data (JSON.gz) |
Producer organisms
| Organism | BGC | Cluster link evidence | Source | Quality | Note | Evidence |
|---|---|---|---|---|---|---|
| Myxococcus xanthus NCBITaxon:34 |
BGC0000955 | — | PRIMARY_LITERATURE_AND_MIBIG | — | The althiomycin NRPS-PKS cluster was identified by gene inactivation; MIBiG BGC0000955 links the characterized cluster. | |
| Serratia marcescens NCBITaxon:615 |
— | — | PRIMARY_LITERATURE | — | Chromatographic and spectroscopic analysis identified althiomycin, and disruption of the alb cluster eliminated production. |
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified ChEBI identity and structure; confirmed protein-synthesis mechanism and corrected target scope with PMID:4917791; added a primary-evidence molecular process target, two producer assertions, two qualitative activity observations, and record-level evidence.
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories